机译:CT引导I-125种子植入晚期胰腺癌的疗效和安全性:META分析
Department of Oncology The Second Hospital of Tianjin Medical University Tianjin China;
Department of Oncology The Second Hospital of Tianjin Medical University Tianjin China;
Department of Oncology The Second Hospital of Tianjin Medical University Tianjin China;
Department of Oncology The Second Hospital of Tianjin Medical University Tianjin China;
Department of Oncology The Second Hospital of Tianjin Medical University Tianjin China;
Department of Oncology The Second Hospital of Tianjin Medical University Tianjin China;
Department of Oncology The Second Hospital of Tianjin Medical University Tianjin China;
Department of Oncology The Second Hospital of Tianjin Medical University Tianjin China;
Department of Oncology The Second Hospital of Tianjin Medical University Tianjin China;
Department of Oncology The Second Hospital of Tianjin Medical University Tianjin China;
Department of Oncology The Second Hospital of Tianjin Medical University Tianjin China;
机译:CT引导I-125种子植入晚期胰腺癌的疗效和安全性:META分析
机译:三维印刷非平板模板辅助和CT引导I-125种子植入外梁放射后复发性腹膜淋巴结转移的剂量测定,疗效和安全性
机译:3D打印模板的安全性和疗效结合放射性I-125种子的CT引导植入治疗胸部恶性肿瘤:单中心,前瞻性,期 - I临床试验
机译:乳腺癌毒素分辨式疗效和安全性的疗效和安全性:META分析
机译:了解受体在胰腺癌中的高级糖化终产物(RAGE)的作用
机译:CT引导I125放射性种子植入的长期安全性和功效作为复发性头部和颈鳞癌的救生疗法:多中心回顾性研究
机译:吉西他滨加抗血管生成治疗治疗晚期胰腺癌的疗效和安全性:临床随机期III试验的系统评价和荟萃分析